With over 18 subspecialties and 60+ experts, we can help with even the most difficult cases.
NEWS & EVENTS
From Health Lab: Study defines key driver of aggressive ovarian cancer
Story originally posted on Michigan Medicine Health Lab, written by Nicole Fawcett.
Study defines key driver of aggressive ovarian cancer
Researchers created a mouse model to understand how the gene CDK12 drives high-grade serous tubo-ovarian carcinoma and identify potential treatment approaches
The Path to Discovery
Jennifer Brazil, PhD, Assistant Professor of Pathology at Michigan Medicine began her own research laboratory in 2018. She continued to research the mechanisms by which polymorphonuclear neutrophils (PMN) and epithelial glycans can be targeted to alter neutrophil transepithelial migration and neutrophil function under conditions of intestinal inflammation and repair.
Enhancing Heart Failure Patient Care with the MOS Dashboard
Heart failure with reduced ejection fraction (HFrEF), which measures your heart’s ability to pump oxygen-rich blood out to your body, remains a leading cause of death and hospitalization worldwide. Over the last three decades, clinical trials have highlighted the efficacy of four key medication classes- Beta-blockers, angiotensin-converting enzyme inhibitors (ACEis), angiotensin receptor-neprilysin inhibitors (ARNI), and sodium-glucose cotransporter 2 inhibitors (SGLT2i).
